drugset / Trial / NCT00382161

Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors

NCT00382161

Phase 3 Withdrawn 20 enrolled University Hospital, Saarland Novartis · collab
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to determine the effect of fluvastatin on penile arterial blood flow and erectile function in patients with arteriogenic ED and cardiovascular risk factors.

Timeline

Start
2006-10
Primary completion
Completion
2007-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluvastatin Other / unclassified 80 mg